BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang T, Xue P, Wang A, Yin M, Han J, Tang S, Liang R. Pore change during degradation of octreotide acetate-loaded PLGA microspheres: The effect of polymer blends. European Journal of Pharmaceutical Sciences 2019;138:104990. [DOI: 10.1016/j.ejps.2019.104990] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
Number Citing Articles
1 Litauszki K, Igriczné ÉK, Pamlényi K, Szarka G, Kmetty Á, Kovács Z. Controlled drug release from laser treated polymeric carrier. J Pharm Sci 2022:S0022-3549(22)00355-0. [PMID: 36007558 DOI: 10.1016/j.xphs.2022.08.018] [Reference Citation Analysis]
2 Bassand C, Freitag J, Benabed L, Verin J, Siepmann F, Siepmann J. PLGA implants for controlled drug release: Impact of the diameter. Eur J Pharm Biopharm 2022:S0939-6411(22)00116-3. [PMID: 35659920 DOI: 10.1016/j.ejpb.2022.05.020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Muddineti OS, Omri A. Current trends in PLGA based long-acting injectable products: The industry perspective. Expert Opin Drug Deliv 2022. [PMID: 35534912 DOI: 10.1080/17425247.2022.2075845] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
4 Bassand C, Benabed L, Verin J, Danede F, Lefol L, Willart J, Siepmann F, Siepmann J. Hot melt extruded PLGA implants loaded with ibuprofen: How heat exposure alters the physical drug state. Journal of Drug Delivery Science and Technology 2022. [DOI: 10.1016/j.jddst.2022.103432] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Lim YW, Tan WS, Ho KL, Mariatulqabtiah AR, Abu Kasim NH, Abd. Rahman N, Wong TW, Chee CF. Challenges and Complications of Poly(lactic-co-glycolic acid)-Based Long-Acting Drug Product Development. Pharmaceutics 2022;14:614. [DOI: 10.3390/pharmaceutics14030614] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
6 Encinas-Basurto D, Konhilas JP, Polt R, Hay M, Mansour HM. Glycosylated Ang-(1-7) MasR Agonist Peptide Poly Lactic-co-Glycolic Acid (PLGA) Nanoparticles and Microparticles in Cognitive Impairment: Design, Particle Preparation, Physicochemical Characterization, and In Vitro Release. Pharmaceutics 2022;14:587. [PMID: 35335963 DOI: 10.3390/pharmaceutics14030587] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Hao L, Jiang Y, Zhang R, Zhang N, Yang Y, Gao Y, Song Y. Preparation and in vivo/in vitro characterization of Ticagrelor PLGA sustained-release microspheres for injection. Des Monomers Polym 2021;24:305-19. [PMID: 34650328 DOI: 10.1080/15685551.2021.1984008] [Reference Citation Analysis]
8 Zhai J, Ou Z, Zhong L, Wang YE, Cao LP, Guan S. Exenatide-loaded inside-porous poly(lactic-co-glycolic acid) microspheres as a long-acting drug delivery system with improved release characteristics. Drug Deliv 2020;27:1667-75. [PMID: 33241694 DOI: 10.1080/10717544.2020.1850919] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Xie X, Wang J, Zhang L, Zeng S, Su X, Chen Q. Bioresorbable Depot for Sustained Release of Immunostimulatory Resiquimod in Suppressing Both Primary Triple-Negative Breast Tumors and Metastatic Occurrence. Bioconjug Chem 2021;32:1008-16. [PMID: 33882675 DOI: 10.1021/acs.bioconjchem.1c00171] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Baino F, Fiume E, Ciavattini S, Kargozar S, Borges R, Genova LA, Marchi J, Verné E. Biomedical Radioactive Glasses for Brachytherapy. Materials (Basel) 2021;14:1131. [PMID: 33673726 DOI: 10.3390/ma14051131] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
11 Xiao P, Qi P, Chen J, Song Z, Wang Y, He H, Tang X, Wang P. The effect of polymer blends on initial release regulation and in vitro-in vivo relationship of peptides loaded PLGA-Hydrogel Microspheres. Int J Pharm 2020;591:119964. [PMID: 33137449 DOI: 10.1016/j.ijpharm.2020.119964] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
12 Nkanga CI, Fisch A, Rad-Malekshahi M, Romic MD, Kittel B, Ullrich T, Wang J, Krause RWM, Adler S, Lammers T, Hennink WE, Ramazani F. Clinically established biodegradable long acting injectables: An industry perspective. Adv Drug Deliv Rev 2020;167:19-46. [PMID: 33202261 DOI: 10.1016/j.addr.2020.11.008] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 14.5] [Reference Citation Analysis]
13 Jin H, Chong H, Zhu Y, Zhang M, Li X, Bazybek N, Wei Y, Gong F, He Y, Ma G. Preparation and evaluation of amphipathic lipopeptide-loaded PLGA microspheres as sustained-release system for AIDS prevention. Eng Life Sci 2020;20:476-84. [PMID: 33204234 DOI: 10.1002/elsc.202000026] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Sharifi F, Otte A, Yoon G, Park K. Continuous in-line homogenization process for scale-up production of naltrexone-loaded PLGA microparticles. J Control Release 2020;325:347-58. [PMID: 32645336 DOI: 10.1016/j.jconrel.2020.06.023] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 8.5] [Reference Citation Analysis]
15 Kamali H, Atamanesh M, Kaffash E, Mohammadpour F, Khodaverdi E, Hadizadeh F. Elimination of residual solvent from PLGA microspheres containing risperidone using supercritical carbon dioxide. Journal of Drug Delivery Science and Technology 2020;57:101702. [DOI: 10.1016/j.jddst.2020.101702] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
16 Zhang C, Yang L, Wan F, Bera H, Cun D, Rantanen J, Yang M. Quality by design thinking in the development of long-acting injectable PLGA/PLA-based microspheres for peptide and protein drug delivery. Int J Pharm 2020;585:119441. [PMID: 32442645 DOI: 10.1016/j.ijpharm.2020.119441] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 16.5] [Reference Citation Analysis]
17 Molavi F, Barzegar-jalali M, Hamishehkar H. Polyester based polymeric nano and microparticles for pharmaceutical purposes: A review on formulation approaches. Journal of Controlled Release 2020;320:265-82. [DOI: 10.1016/j.jconrel.2020.01.028] [Cited by in Crossref: 68] [Cited by in F6Publishing: 71] [Article Influence: 34.0] [Reference Citation Analysis]